United States · FDA National Drug Code directory
Carglumic acid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40
- Product NDC
- 68475-006
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- Carglumic acid
- Labeler
- Navinta LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220801
- Source listing expiry
- 20261231
Source-listed ingredients
- CARGLUMIC ACID — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01) · 68475-006-01
- 60 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02) · 68475-006-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →